Stocks and Investing Stocks and Investing
Tue, June 7, 2022

Jonathan Chang Maintained (VINC) at Buy with Decreased Target to $6 on, Jun 7th, 2022


Published on 2024-10-27 21:25:45 - WOPRAI, Jonathan Chang
  Print publication without navigation


Jonathan Chang of SVB Leerink, Maintained "Vincerx Pharma, Inc." (VINC) at Buy with Decreased Target from $19 to $6 on, Jun 7th, 2022.

Jonathan has made no other calls on VINC in the last 4 months.



There is 1 other peer that has a rating on VINC. Out of the 1 peers that are also analyzing VINC, 0 agree with Jonathan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jonathan


  • Michael King of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $28 on, Wednesday, March 30th, 2022
Contributing Sources